Doconexent

Overview IFRA Request a quote

  • Identifiers

    CAS number
    25167-62-8

    Molecular formula
    C22H32O2

    SMILES
    CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O

    Safety labels

  • Properties

    XLogP3-AA
    6.2

    Molecular weight
    328.5 g/mol

  • Synonyms

    • Doconexent
    • Doconexento
    • Doconexentum
    • Doxonexent
    • AquaGrow Advantage
    • Martek DHA HM
    • Ropufa 60
    • Monolife 50
    • CCRIS 7670
    • UNII-ZAD9OKH9JC
    • ZAD9OKH9JC
    • Doconexentum [INN-Latin]
    • Doconexento [INN-Spanish]
    • C22:6 (n-3)
    • 22:6 n-3
    • CHEBI:28125
    • Doconexentum (INN-Latin)
    • Doconexento (INN-Spanish)
    • Complete Natal DHA
    • WesNatal DHA Complete
    • RefChem:34997
    • OBTREX DHA Combo Pack
    • Obstetrix DHA Combo Pack
    • Select-OB Plus DHAPrenatal Supplement Plus DHA
    • Vitafol-OB Plus DHAPrenatal Supplement Plus DHA
    • 22:6
    • 25167-62-8
    • CHEBI:36005
    • Docosahexaenoic Acid
    • DTXSID401018161
    • RefChem:5773
    • Retriacyl (proposed trade name)
    • Cervonic acid
    • 6217-54-5
    • cis-4,7,10,13,16,19-Docosahexaenoic acid
    • (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid
    • Docosahexaenoate
    • all-cis-DHA
    • all-Z-Docosahexaenoic acid
    • Doconexent [INN]
    • all-cis-4,7,10,13,16,19-Docosahexaenoic acid
    • MFCD00065722
    • (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid
    • Algal DHA
    • Docosaheaenoic-acid
    • Docosahexaenoic acid (all-Z)
    • all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
    • (all-Z)-4,7,10,13,16,19-Docosahexaenoic acid
    • DOCOSAHEXANOIC ACID
    • FA 22:6
    • (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-Docosahexaenoic acid
    • 4,7,10,13,16,19-Docosahexaenoic acid, (all-Z)-
    • CHEMBL367149
    • DTXSID5040465
    • 22:6(n-3)
    • delta4,7,10,13,16,19-Docosahexaenoic acid
    • 4-cis,7-cis,10-cis,13-cis,16-cis,19-cis-Docosahexaenoic acid
    • 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
    • Docosahexaenoic acid (c22:6 n3)
    • efalex
    • NCGC00161345-04
    • DOCOSAHEXAENOIC ACID (22:6 n-3)
    • cis-4,7,10,13,16,19-Docosahexanoic acid
    • DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID
    • A320050000
    • C22:6n-3,6,9,12,15,18
    • Marinol D 50TG
    • 4,7,10,13,16,19-Docosahexaenoic acid, (4Z,7Z,10Z,13Z,16Z,19Z)-
    • SR-05000002130
    • Cervonate
    • Cervonic AcidDHA
    • 1fdq
    • Docohexanenoic Acid
    • Docosahexanenoic acid
    • all-Z-Docosahexaenoate
    • DHA/Docosahexaenoic acid
    • Spectrum5_002062
    • Docosahexaenoic acid (6CI)
    • SCHEMBL19577
    • BSPBio_001298
    • MLS004773950
    • BML3-B02
    • GTPL1051
    • Docosahexaenoic acid (Standard)
    • DTXCID3020465
    • BCBcMAP01_000145
    • HY-B2167R
    • DOCOSAHEXAENOIC ACID [MI]
    • HMS1361A20
    • HMS1791A20
    • HMS1989A20
    • HMS3402A20
    • HMS3649J15
    • HMS5085D04
    • Docosahexaenoic Acid; Cervonic Acid
    • HY-B2167
    • DOCOSAHEXAENOIC ACID [VANDF]
    • Tox21_111992
    • BDBM50210259
    • DOCOSAHEXAENOIC ACID [MART.]
    • EBC-26606
    • LMFA01030185
    • DOCOSAHEXAENOIC ACID [USP-RS]
    • DOCOSAHEXAENOIC ACID [WHO-DD]
    • AKOS015962159
    • AC-1010
    • CCG-207958
    • CCG-208135
    • CS-6261
    • DB03756
    • FD01734
    • KL-0761
    • IDI1_033768
    • 4,7,10,13,16,19-Docosahexaenoate
    • NCGC00161345-01
    • NCGC00161345-02
    • NCGC00161345-03
    • NCGC00161345-05
    • NCGC00161345-07
    • all cis- Docosahexaenoic acid (cis-DHA)
    • BP-29833
    • SMR001881493
    • SY014871
    • 2,5,8,11,14,17-docosahexaenoic acid
    • CAS-6217-54-5
    • cis-4,7,10,13,16,19-Docosahexanoate
    • D2226
    • 25167-62-8

  • Applications

    Doconexent (CAS 25167-62-8) has multiple industrial applications, typically as an intermediate in organic synthesis; as a solvent or processing aid in industrial formulations; as a stabilizer or plasticizer in polymer systems; used in coatings and inks as a solvent or additive; used in adhesive formulations; may be evaluated for cleaning formulations; and may be explored for electronics manufacturing as a processing aid.

    gpt-5-nano

1 3

IFRA standard 51

Recommendation
No restriction
Maximum acceptable concentrations in the finished product (%)
Category 1
Products applied to the lips
 No restriction Category 7A
Rinse-off products applied to the hair with some hand contact
 No restriction
Category 2
Products applied to the axillae
 No restriction Category 7B
Leave-on products applied to the hair with some hand contact
 No restriction
Category 3
Products applied to the face/body using fingertips
 No restriction Category 8
Products with significant anogenital exposure
 No restriction
Category 4
Products related to fine fragrance
 No restriction Category 9
Products with body and hand exposure, primarily rinse off
 No restriction
Category 5A
Body lotion products applied to the body using the hands (palms), primarily leave on
 No restriction Category 10A
Household care products with mostly hand contact
 No restriction
Category 5B
Face moisturizer products applied to the face using the hands (palms), primarily leave on
 No restriction Category 10B
Household care products with mostly hand contact, including aerosol/spray products (with potential leave-on skin contact)
 No restriction
Category 5C
Hand cream products applied to the hands using the hands (palms), primarily leave on
 No restriction Category 11A
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate without UV exposure
 No restriction
Category 5D
Baby Creams, baby Oils and baby talc
 No restriction Category 11B
Products with intended skin contact but minimal transfer of fragrance to skin from inert substrate with potential UV exposure
 No restriction
Category 6
Products with oral and lip exposure
 No restriction Category 12
Products not intended for direct skin contact, minimal or insignificant transfer to skin
 No restriction